WallStreetZenWallStreetZen

NASDAQ: RNLX
Renalytix PLC Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for RNLX

Based on 3 analysts offering 12 month price targets for Renalytix PLC.
Min Forecast
$5.00+270.37%
Avg Forecast
$9.00+566.67%
Max Forecast
$15.00+1,011.11%

Should I buy or sell RNLX stock?

Based on 3 analysts offering ratings for Renalytix PLC.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RNLX stock forecasts and price targets.

RNLX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
BTIG
Top 31%
70
Strong BuyMaintains$5.00+270.37%2022-07-01
Stifel Nicolaus
Top 9%
92
Strong BuyMaintains$7.00+418.52%2022-07-01
HC Wainwright & Co.
Top 5%
96
BuyMaintains$15.00+1,011.11%2022-07-01

1 of 1

Forecast return on equity

Is RNLX forecast to generate an efficient return?
Company
-140.12%
Industry
535.43%
Market
110.54%
RNLX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RNLX forecast to generate an efficient return on assets?
Company
-92.69%
Industry
11.42%
RNLX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RNLX earnings per share forecast

What is RNLX's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.60
Avg 2 year Forecast
-$0.57

RNLX revenue forecast

What is RNLX's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$11.8M+351.93%
Avg 2 year Forecast
$43.3M+1,558.37%
RNLX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RNLX revenue growth forecast

How is RNLX forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
307.23%
Industry
3.87%
Market
8.49%
RNLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RNLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RNLX vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
RNLX$1.35$9.00+566.67%Strong Buy
LHDX$1.19$3.50+194.12%Hold
XGN$2.84$17.00+498.59%Strong Buy
AWH$0.41$3.00+635.29%Strong Buy
SERA$1.73$11.75+579.19%Buy

Renalytix Stock Forecast FAQ

Is Renalytix Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: RNLX) stock is to Strong Buy RNLX stock.

Out of 3 analysts, 2 (66.67%) are recommending RNLX as a Strong Buy, 1 (33.33%) are recommending RNLX as a Buy, 0 (0%) are recommending RNLX as a Hold, 0 (0%) are recommending RNLX as a Sell, and 0 (0%) are recommending RNLX as a Strong Sell.

If you're new to stock investing, here's how to buy Renalytix stock.

What is RNLX's earnings growth forecast for 2023-2024?

(NASDAQ: RNLX) Renalytix's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 14.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.09%.

Renalytix's earnings in 2022 is -$49,943,000.On average, 2 Wall Street analysts forecast RNLX's earnings for 2023 to be -$43,385,358, with the lowest RNLX earnings forecast at -$48,446,983, and the highest RNLX earnings forecast at -$38,323,733.

In 2024, RNLX is forecast to generate -$41,216,090 in earnings, with the lowest earnings forecast at -$41,216,090 and the highest earnings forecast at -$41,216,090.

What is RNLX's revenue growth forecast for 2023-2024?

(NASDAQ: RNLX) Renalytix's forecast annual revenue growth rate of 307.23% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.87%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.49%.

Renalytix's revenue in 2022 is $2,611,000.On average, 2 Wall Street analysts forecast RNLX's revenue for 2023 to be $853,245,374, with the lowest RNLX revenue forecast at $846,014,481, and the highest RNLX revenue forecast at $860,476,267.

In 2024, RNLX is forecast to generate $3,130,976,669 in revenue, with the lowest revenue forecast at $3,130,976,669 and the highest revenue forecast at $3,130,976,669.

What is RNLX's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: RNLX) forecast ROA is -92.69%, which is lower than the forecast US Diagnostics & Research industry average of 11.42%.

What is RNLX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year RNLX price target, the average RNLX price target is $9.00, with the highest RNLX stock price forecast at $15.00 and the lowest RNLX stock price forecast at $5.00.

On average, Wall Street analysts predict that Renalytix's share price could reach $9.00 by Jul 1, 2023. The average Renalytix stock price prediction forecasts a potential upside of 566.67% from the current RNLX share price of $1.35.

What is RNLX's Earnings Per Share (EPS) forecast for 2023-2024?

(NASDAQ: RNLX) Renalytix's current Earnings Per Share (EPS) is -$1.38. On average, analysts forecast that RNLX's EPS will be -$0.60 for 2023, with the lowest EPS forecast at -$0.67, and the highest EPS forecast at -$0.53. In 2024, RNLX's EPS is forecast to hit -$0.57 (min: -$0.57, max: -$0.57).

What is RNLX's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: RNLX) forecast ROE is -140.12%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.